๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Systemic mitomycin C versus cisplatin: comparison of antitumor activity in primary murine bladder cancer

โœ Scribed by Stanley C. Hopkins; Robert Matheny; Mark S. Soloway


Book ID
119044715
Publisher
Elsevier Science
Year
1982
Tongue
English
Weight
279 KB
Volume
20
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Synergistic antitumor activity of mitomy
โœ Yoshiro Saikawa; Tetsuro Kubota; Tsong-Hong Kuo; Suguru Kase; Toshiharu Furukawa ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 466 KB

The synergistic antitumor activity of mitomycin C (MMC) and cisplatin (DDP) against the gastric cancer cell lines MKN-28 and MKN-45 was assessed in vitro using the MTT assay. The synergism of the two agents was evaluated in terms of the interaction index (1.1.). The sequence of MMC followed by DDP s

Synergistic antitumor activity of combin
โœ Yoshiro Saikawa; Dr. Tetsuro Kubota; Tsong-Hong Kuo; Toshiharu Furukawa; Suguru ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 363 KB

A new combined cancer chemotherapy regimen of mitomycin C (MMC) and cisplatin (DDP) showed synergistic antitumor activity against human gastric cancer xenografts St-40 and SC-1-NU in BALB/c nu/nu mice. The drugs were administered intraperitoneally at doses of 2 or 4 mg/kg for MMC and 3 or 6 mg/kg fo